diabetes management
Preventing diabetes complications
The key aim of diabetes management is to prevent complications, which are a major cause of morbidity and mortality. By Debbie Rigby, advanced practice pharmacist Learning Objectives After completing this …
Identifying complications of diabetes: the pharmacist’s role
This article discusses the various medical conditions that may occur more frequently with, or as a complication of diabetes. By Karalyn Huxhagen BPharm, FPS, FANZCAP (CommPharm, PrimCare), community pharmacist and …
Diabetes in older persons
The increasing prevalence of type 2 diabetes among older persons highlights the need for pharmacists conducting medication reviews to remain up to date with shifting evidence and guidelines. By Debbie …
Boost needed for pharmacy diabetes role
Pharmacists in rural and remote locations need more financial support and education to service travellers who have diabetes needs, research finds Rural and remote pharmacies are often the first port …
Insulin resistance insights revealed
Healthcare professionals can foster timely insulin initiation by supporting patients with realistic, accurate perceptions of diabetes and its treatment from day one. A recent study1 provides insights into some of …
Not so sweet
Guidelines are flawed and must be revised as type 2 diabetes is reversible, says the 2020 Australian of the Year. Dietary1 and clinical guidelines2 must change along with our love …
Cost of continuous glucose monitoring prohibitive for most
Findings released from one of the largest surveys of people with type 1 diabetes (T1D) reveals the cost of managing the condition is resulting in poor health outcomes, including depression. …
Lockdown linked to rise in gestational diabetes
Melbourne lockdowns see gestational diabetes cases rise, while experts warn women are missing out on funded-education and support. COVID lockdowns could be behind an increase seen in the rate of …
Diabetes Updates
‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 …